Adenomatous polyposis coli 1A is likely to be methylated as a passenger in human gastric carcinogenesis

Cancer Letters

Volumn 285, Issue 2, 2009, Pages 182-189

  Hosoya, Kosuke ^a,c   Yamashita, Satoshi ^a   Ando, Takayuki ^a   Nakajima, Takeshi ^b   Itoh, Fumio ^c   Ushijima, Toshikazu ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

^c ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

DNA methylation; Epigenetics; Gastric cancer; Helicobacter pylori; Passenger

Indexed keywords

APC PROTEIN;

ADULT; AGED; ARTICLE; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DNA METHYLATION; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; STOMACH CANCER; STOMACH CARCINOGENESIS; STOMACH MUCOSA; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION; VOLUNTEER;

ADENOMATOUS POLYPOSIS COLI PROTEIN; CPG ISLANDS; DNA METHYLATION; DOWN-REGULATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENES, APC; HUMANS; MALE; MIDDLE AGED; PROMOTER REGIONS, GENETIC; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS;

HELICOBACTER PYLORI;

EID: 70349956449     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2009.05.016     Document Type: Article

References (34)

1. Jones P.A., and Baylin S.B. The epigenomics of cancer. Cell 128 (2007) 683-692
2. Ushijima T. Detection and interpretation of altered methylation patterns in cancer cells. Nat. Rev. Cancer 5 (2005) 223-231
3. Weber M., Davies J.J., Wittig D., Oakeley E.J., Haase M., Lam W.L., and Schubeler D. Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat. Genet. 37 (2005) 853-862
4. Keshet I., Schlesinger Y., Farkash S., Rand E., Hecht M., Segal E., Pikarski E., Young R.A., Niveleau A., Cedar H., and Simon I. Evidence for an instructive mechanism of de novo methylation in cancer cells. Nat. Genet. 38 (2006) 149-153
5. Yamashita S., Tsujino Y., Moriguchi K., Tatematsu M., and Ushijima T. Chemical genomic screening for methylation-silenced genes in gastric cancer cell lines using 5-aza-2′-deoxycytidine treatment and oligonucleotide microarray. Cancer Sci. 97 (2006) 64-71
6. Nakajima T., Yamashita S., Maekita T., Niwa T., Nakazawa K., and Ushijima T. The presence of a methylation fingerprint of Helicobacter pylori infection in human gastric mucosae. Int. J. Cancer 124 (2009) 905-910
7. Ushijima T., and Sasako M. Focus on gastric cancer. Cancer Cell 5 (2004) 121-125
8. Tsugane S., and Sasazuki S. Diet and the risk of gastric cancer: review of epidemiological evidence. Gastric Cancer 10 (2007) 75-83
9. Maekita T., Nakazawa K., Mihara M., Nakajima T., Yanaoka K., Iguchi M., Arii K., Kaneda A., Tsukamoto T., Tatematsu M., Tamura G., Saito D., Sugimura T., Ichinose M., and Ushijima T. High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. Clin. Cancer Res. 12 (2006) 989-995
10. Nakajima T., Maekita T., Oda I., Gotoda T., Yamamoto S., Umemura S., Ichinose M., Sugimura T., Ushijima T., and Saito D. Higher methylation levels in gastric mucosae significantly correlate with higher risk of gastric cancers. Cancer Epidemiol. Biomark. Prev. 15 (2006) 2317-2321
11. Ushijima T. Epigenetic field for cancerization. J. Biochem. Mol. Biol. 40 (2007) 142-150
12. Yamamoto E., Toyota M., Suzuki H., Kondo Y., Sanomura T., Murayama Y., Ohe-Toyota M., Maruyama R., Nojima M., Ashida M., Fujii K., Sasaki Y., Hayashi N., Mori M., Imai K., Tokino T., and Shinomura Y. LINE-1 hypomethylation is associated with increased CpG island methylation in Helicobacter pylori-related enlarged-fold gastritis. Cancer Epidemiol. Biomark. Prev. 17 (2008) 2555-2564
13. Ando T., Yoshida T., Enomoto S., Asada K., Tatematsu M., Ichinose M., Sugiyama T., and Ushijima T. DNA methylation of microRNA genes in gastric mucosae of gastric cancer patients: its possible involvement in the formation of epigenetic field defect. Int. J. Cancer 124 (2009) 2367-2374
14. Akiyama T. Wnt/beta-catenin signaling. Cytokine Growth Factor Rev. 11 (2000) 273-282
15. Kikuchi A. Tumor formation by genetic mutations in the components of the Wnt signaling pathway. Cancer Sci. 94 (2003) 225-229
16. Klaus A., and Birchmeier W. Wnt signalling and its impact on development and cancer. Nat. Rev. Cancer 8 (2008) 387-398
17. Tsuchiya T., Tamura G., Sato K., Endoh Y., Sakata K., Jin Z., Motoyama T., Usuba O., Kimura W., Nishizuka S., Wilson K.T., James S.P., Yin J., Fleisher A.S., Zou T., Silverberg S.G., Kong D., and Meltzer S.J. Distinct methylation patterns of two APC gene promoters in normal and cancerous gastric epithelia. Oncogene 19 (2000) 3642-3646
18. Esteller M., Sparks A., Toyota M., Sanchez-Cespedes M., Capella G., Peinado M.A., Gonzalez S., Tarafa G., Sidransky D., Meltzer S.J., Baylin S.B., and Herman J.G. Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer. Cancer Res. 60 (2000) 4366-4371
19. Kang G.H., Lee S., Kim J.S., and Jung H.Y. Profile of aberrant CpG island methylation along the multistep pathway of gastric carcinogenesis. Lab Invest. 83 (2003) 635-641
20. Sarbia M., Geddert H., Klump B., Kiel S., Iskender E., and Gabbert H.E. Hypermethylation of tumor suppressor genes (p16INK4A, p14ARF and APC) in adenocarcinomas of the upper gastrointestinal tract. Int. J. Cancer 111 (2004) 224-228
21. Perri F., Cotugno R., Piepoli A., Merla A., Quitadamo M., Gentile A., Pilotto A., Annese V., and Andriulli A. Aberrant DNA methylation in non-neoplastic gastric mucosa of H. Pylori infected patients and effect of eradication. Am. J. Gastroenterol. 102 (2007) 1361-1371
22. Horii A., Nakatsuru S., Miyoshi Y., Ichii S., Nagase H., Kato Y., Yanagisawa A., and Nakamura Y. The APC, generesponsible for familial adenomatous polyposis is mutated in human gastric cancer. Cancer Res. 52 (1992) 3231-3233
23. Horii A., Nakatsuru S., Ichii S., Nagase H., and Nakamura Y. Multiple forms of the APC gene transcripts and their tissue-specific expression. Hum. Mol. Genet. 2 (1993) 283-287
24. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol. Microbiol. Scand. 64 (1965) 31-49
25. Kaneda A., Kaminishi M., Sugimura T., and Ushijima T. Decreased expression of the seven ARP2/3 complex genes in human gastric cancers. Cancer Lett. 212 (2004) 203-210
26. Yokozaki H. Molecular characteristics of eight gastric cancer cell lines established in Japan. Pathol. Int. 50 (2000) 767-777
27. Lin J.C., Jeong S., Liang G., Takai D., Fatemi M., Tsai Y.C., Egger G., Gal-Yam E.N., and Jones P.A. Role of nucleosomal occupancy in the epigenetic silencing of the MLH1 CpG island. Cancer Cell 12 (2007) 432-444
28. Boussioutas A., Li H., Liu J., Waring P., Lade S., Holloway A.J., Taupin D., Gorringe K., Haviv I., Desmond P.V., and Bowtell D.D. Distinctive patterns of gene expression in premalignant gastric mucosa and gastric cancer. Cancer Res. 63 (2003) 2569-2577
29. Min/+ mice by the activation of the beta-catenin/Tcf signaling pathway. Cancer Res. 67 (2007) 4079-4087
30. Maruyama R., Toyooka S., Toyooka K.O., Harada K., Virmani A.K., Zochbauer-Muller S., Farinas A.J., Vakar-Lopez F., Minna J.D., Sagalowsky A., Czerniak B., and Gazdar A.F. Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features. Cancer Res. 61 (2001) 8659-8663
31. Maruyama R., Toyooka S., Toyooka K.O., Virmani A.K., Zochbauer-Muller S., Farinas A.J., Minna J.D., McConnell J., Frenkel E.P., and Gazdar A.F. Aberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological features. Clin. Cancer Res. 8 (2002) 514-519
32. Virmani A.K., Rathi A., Sathyanarayana U.G., Padar A., Huang C.X., Cunnigham H.T., Farinas A.J., Milchgrub S., Euhus D.M., Gilcrease M., Herman J., Minna J.D., and Gazdar A.F. Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas. Clin. Cancer Res. 7 (2001) 1998-2004
33. Worm J., Christensen C., Gronbaek K., Tulchinsky E., and Guldberg P. Genetic and epigenetic alterations of the APC gene in malignant melanoma. Oncogene 23 (2004) 5215-5226
34. Csepregi A., Rocken C., Hoffmann J., Gu P., Saliger S., Muller O., Schneider-Stock R., Kutzner N., Roessner A., Malfertheiner P., and Ebert M.P. APC promoter methylation and protein expression in hepatocellular carcinoma. J. Cancer Res. Clin. Oncol. 134 (2008) 579-589